Bellecapital International Ltd. Staar Surgical CO Transaction History

Bellecapital International Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 07, 2023	SELL	$50.45 - $72.82 $132,834 - $191,735	-2,633 Reduced 31.3%	5,779 $303,000
Q1 2023 Apr 25, 2023	BUY	$51.25 - $79.34 $11,531 - $17,851	225 Added 2.75%	8,412 $537,000
Q4 2022 Feb 10, 2023	SELL	$46.82 - $76.2 $10,534 - $17,145	-225 Reduced 2.67%	8,187 $397,000
Q3 2022 Nov 07, 2022	BUY	$70.55 - $111.58 $7,055 - $11,158	100 Added 1.2%	8,412 $593,000
Q2 2022 Jul 27, 2022	SELL	$50.24 - $80.48 $5,024 - $8,048	-100 Reduced 1.19%	8,312 $590,000
Q4 2021 Jan 20, 2022	SELL	$88.02 - $127.79 $12,058 - $17,507	-137 Reduced 1.6%	8,412 $768,000
Q1 2021 Apr 13, 2021	SELL	$78.5 - $126.48 $381,510 - $614,692	-4,860 Reduced 36.24%	8,549 $901,000
Q4 2020 Jan 14, 2021	SELL	$55.93 - $82.78 $104,700 - $154,964	-1,872 Reduced 12.25%	13,409 $1.06 Million
Q3 2020 Oct 16, 2020	BUY	$45.65 - $61.81 $697,577 - $944,518	15,281 New	15,281 $864,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

Stay updated on Bellecapital International Ltd. with notifications on news.